Switzerland · Biotechnology startup

Idorsia

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.

Funding reportedLast round: Post-IPO Debt

BiotechnologyAllschwil, Switzerland

What company datasets say Idorsia raised

Funding, as reported

Reported in all1.5Bin the source's currency
Rounds6
Last roundPost-IPO Debt
Last round dateJun 2023
Investors listed3

Founders and team

From Idorsia's own website: 8 on the team.

  • Roland WandelerChief Executive Officer
  • Amel DjedourSenior Vice President, Head of Technical Operations
  • Gaby SchererSenior Vice President, Head of Global Human Resources
  • Shal JacobovitzPresident of Idorsia US
  • Gabriel BaertschiChairman
  • Mathieu SimonChairman
  • Organisational RegulationsJean-Paul Clozel, Chairman of the Board
  • Sandy MahatmeChairman

Biotechnology in Switzerland

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Idorsia in front of investors. Or tell us what we have wrong.

List your startupSend a correction